Orthofix Medical (OFIX) Net Cash Flow (2010 - 2026)

Orthofix Medical (OFIX) has 17 years of Net Cash Flow data on file, last reported at $35.8 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 239.05% year-over-year to $35.8 million; the trailing twelve-month figure through Mar 2026 stood at $59.6 million (up 91.29% YoY), and the FY2025 full-year result was -$2.0 million, down 104.16% from the prior year.
• Net Cash Flow for Q1 2026 stood at $35.8 million, up from $19.2 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $54.1 million in Q4 2024 and bottomed at -$25.8 million in Q1 2025.
• A 5-year average of $1.9 million and a median of -$2.1 million in 2022 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow plunged 1169.02% in 2022 and soared 1516.57% in 2025, its largest moves.
• Tracing OFIX's Net Cash Flow over 5 years: stood at -$2.1 million in 2022, then surged by 272.01% to $3.5 million in 2023, then jumped by 1430.77% to $54.1 million in 2024, then tumbled by 64.49% to $19.2 million in 2025, then jumped by 86.66% to $35.8 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered $35.8 million, $19.2 million, and -$2.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison